Cara Therapeutics | CARA - Ebitda





Ebitda Veränderung Datum
Acadia Pharmaceuticals USD 40.99M 42.62M 2026-06
Alterity Therapeutics Limited AUD -7.72M 2.99M 2023-06
Cara Therapeutics USD -2.39M 3.16M 2025-03
Cassava Sciences USD -11.73M 33.44M 2025-09
Chugai Pharma JPY 193.44B 23.07B 2026-09
Cipla INR 13.88B 154.2M 2026-09
Clal Biotechnology ILS -5.3M 2.09M 2022-12
Compugen USD -8.84M 180K 2026-06
CSL USD 3.13B 1.17B 2025-12
Grifols EUR 482.04M 7.04M 2025-09
Halozyme Therapeutics USD 336.16M 7.34M 2026-09
J&J USD 8.99B 721M 2026-06
Neurocrine Biosciences USD 375.3M 185.4M 2026-09
Pacira USD 48.67M 8.43M 2026-06
Pfizer USD 6.36B 350M 2026-09
RedHill Biopharma USD 2.69M 108.46M 2023-06
Supernus Pharmaceuticals USD 55.6M 24M 2026-09
Vanda Pharmaceuticals USD -8.31M 2.37M 2024-12